We know that cancer research brilliance goes further, faster, when it’s backed by technology.
So we ask highly-esteemed cancer researchers to select the cancer research they believe in, and we supercharge it with technology. It works!
Australian Cancer Research Foundation’s approach has already saved the lives of Australians who would otherwise die from their cancer or pay an unacceptable price for more time. 2 in 5 Australians will be diagnosed with cancer by the age of 85. The remaining 3 will be closely affected by a diagnosis.
Support ACRF, as people you love need Australia’s best cancer research.
We gave the initial seed funding to Professor Ian Frazer’s research into the development of a cervical cancer vaccine. The vaccine has now been administered to millions globally.
ACRF’s long-term support of cancer research at Walter and Eliza Hall Institute (WEHI) has seen the support of a revolutionary treatment that melts away certain advanced forms of Chronic Lymphocytic Leukemia. This treatment is currently being trialed for the improved treatment of lung and prostate cancers.
ACRF’s major grant of 2018 supported the ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID). The project supporting the vision of a ‘world without melanoma’ is aiming to be one of the largest melanoma surveillance and early detection programs in the world.
The program name is also the aim. Focusing on children across Australia diagnosed with the most high-risk cancers, this world-first personalised medicine program already has over 1,000 children enrolled. The ultimate aim of the program is to see zero deaths from childhood cancer.
Your support helps ACRF provide world-class scientists with the technology, equipment and infrastructure they need to develop better prevention, earlier detection and more effective treatment across all cancer types.
Your generosity means ACRF can continue to back bold ideas that lead to breakthroughs and discoveries that help each individual diagnosed with this complex and disruptive disease.
You can read some of their stories below.
